NCT01416311View on ClinicalTrials.gov

Drug Use Investigation for REVOLADE (ITP)

CompletedOBSERVATIONAL
Enrollment

5,797

Participants

Timeline

Start Date

December 21, 2010

Primary Completion Date

October 16, 2020

Study Completion Date

October 16, 2020

Conditions
Purpura, Thrombocytopaenic, Idiopathic
Interventions
DRUG

Eltrombopag

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY